254 related articles for article (PubMed ID: 18434328)
1. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
[TBL] [Abstract][Full Text] [Related]
3. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
[TBL] [Abstract][Full Text] [Related]
4. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
[TBL] [Abstract][Full Text] [Related]
5. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
[TBL] [Abstract][Full Text] [Related]
6. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
[TBL] [Abstract][Full Text] [Related]
7. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
Childers MK; Joubert R; Poulard K; Moal C; Grange RW; Doering JA; Lawlor MW; Rider BE; Jamet T; Danièle N; Martin S; Rivière C; Soker T; Hammer C; Van Wittenberghe L; Lockard M; Guan X; Goddard M; Mitchell E; Barber J; Williams JK; Mack DL; Furth ME; Vignaud A; Masurier C; Mavilio F; Moullier P; Beggs AH; Buj-Bello A
Sci Transl Med; 2014 Jan; 6(220):220ra10. PubMed ID: 24452262
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
Elverman M; Goddard MA; Mack D; Snyder JM; Lawlor MW; Meng H; Beggs AH; Buj-Bello A; Poulard K; Marsh AP; Grange RW; Kelly VE; Childers MK
Muscle Nerve; 2017 Nov; 56(5):943-953. PubMed ID: 28370029
[TBL] [Abstract][Full Text] [Related]
10. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
[TBL] [Abstract][Full Text] [Related]
12. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
[TBL] [Abstract][Full Text] [Related]
13. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
[TBL] [Abstract][Full Text] [Related]
14. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
Dowling JJ; Vreede AP; Low SE; Gibbs EM; Kuwada JY; Bonnemann CG; Feldman EL
PLoS Genet; 2009 Feb; 5(2):e1000372. PubMed ID: 19197364
[TBL] [Abstract][Full Text] [Related]
15. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
16. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
[TBL] [Abstract][Full Text] [Related]
17. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
[TBL] [Abstract][Full Text] [Related]
18. The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies.
Royer B; Hnia K; Gavriilidis C; Tronchère H; Tosch V; Laporte J
EMBO Rep; 2013 Oct; 14(10):907-15. PubMed ID: 23917616
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
[TBL] [Abstract][Full Text] [Related]
20. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.
Beggs AH; Böhm J; Snead E; Kozlowski M; Maurer M; Minor K; Childers MK; Taylor SM; Hitte C; Mickelson JR; Guo LT; Mizisin AP; Buj-Bello A; Tiret L; Laporte J; Shelton GD
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14697-702. PubMed ID: 20682747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
